Genetic activation of mTOR results in enhanced beta cell growth and increased insulin secretion in mouse beta cells [39], whereas pharmacological inhibition of mTOR dramatically inhibited insulin secretion and reduced beta cell mass in a rodent model of obesity [40]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.